Search results

Selected filters:


Article type





88 results found for your search

Sort options
13 November 2015

“Politics and self-interest have been having way too much influence on the patent system”

Yesterday we ran the first part of an interview with Steve Borsand the EVP of IP at Trading Technologies, a company that designs financial trading software. In this second part we discuss both the ongoing debate around patent reform and the impact…

10 November 2015

Buying strategies for growing companies; the great "troll" debate; US hope & more at IPBC Asia 2015 Day Two

The plenary and breakout sessions of IPBC Asia 2015 have now come to an end, although many of the 550 delegates are now enjoying one final networking opportunity at the closing drinks reception. Before joining them, IAM’s team of reporters covering…

09 November 2015

US market dominance under serious threat and much more from IPBC Asia 2015 Day One

The plenary and breakout sessions of IPBC Asia 2015 got underway today at the Palace Hotel in Tokyo. Over 550 delegates are in attendance, with a very strong showing of senior corporate IP managers working in Japanese companies and those based in…

04 November 2015

New IAM law and policy event just weeks away

It is three weeks until IAM’s inaugural Patent Law and Policy conference being held in Washington DC on November 17th. It is the first time that we have held an event specifically focused on law and policy. At a time when patent reform is still…

13 October 2015

How courts, legislators and regulatory authorities are fundamentally reshaping the US patent market

In a little over a month’s time, Patent Law and Policy: Courts, Congress and the Monetisation Landscape will take place in Washington DC. Being hosted by IAM at the Ronald Reagan Centre on 17th November, the conference will offer all those…

05 October 2015

The 40 individuals who drive the global patent market named in the latest issue of IAM

Last year we published our inaugural top 40 market makers – our ranking of the main movers and shakers in the global patent transactions and investment market. The list is back again this year, in the latest issue of IAM, with the same aim – lifting…

01 October 2015

IAM 74 now out: why licensing companies face an extinction event & the drivers of the global patent market named

Issue 74 of IAM has now been published and is available for subscribers to read online. Our cover story focuses on how challenging the climate in the US has become for companies whose businesses are based on the generation of patent licensing…

11 September 2015

“Odds of success are just too small now” for licensors, says outgoing WiLAN CEO Jim Skippen

Back in June WiLAN announced that its CEO Jim Skippen would be stepping down after nine years at the helm. When he took the top spot at the Canadian NPE, it had a market capitalisation of less than C$30 million. Today, it stands at well over C$300…

08 September 2015

Former USPTO Commissioner for Patents joins stellar speaking faculty for IAM law and policy event

The former Commissioner for Patents at the US Patent and Trademark Office (USPTO) Margaret (Peggy) Focarino has joined the specialist IP law firm Oblon, McClelland, Maier & Neustadt as a senior patent adviser. It has also been confirmed that she is…

21 July 2015

Acacia is a bellwether NPE and well-placed to ride out current market uncertainties

Acacia Research has in many ways been a trailblazer for the NPE market. It initially pursued a large-scale approach to licensing through a volume-based strategy before shifting to a focus on marquee portfolios. It has expanded its horizons to take…

17 July 2015

The Kyle Bass pharma patent IPR strategy looks to be a lot more sophisticated and long-term than many think

Last week we published an interview with Kyle Bass, the hedge fund investor who together with Erich Spangenberg, has petitioned to challenge a series of pharmaceutical patents through the inter partes review (IPR) process at the Patent Trial and…

16 July 2015

The Innovation Act is pulled, but uncertainty lingers and that’s bad for business

The Innovation Act was dramatically pulled from consideration last night just days before a vote on it was expected in the House of Representatives. It is now unlikely that the proposed legislation will be considered again until after the summer…

10 July 2015

Big pharma is terrified of what I am doing, but I am bringing greater clarity to the market, says Bass

This time a few months ago no-one inside the world of IP would have given Hayman Capital founder and manager Kyle Bass a second thought, unless they were one of his investors. Now, though, his name is on everyone’s lips. Since teaming up with Erich…

17 June 2015

A new approach to the reform debate; China's IP future; the European tide; and much more at IPBC Global Day 3

IPBC Global in San Francisco is now finished, but only after another compelling day of sessions, networking and discussion. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights: …

16 June 2015

Patent values about to climb, heroic inventors, the US's patent failure, hope for SMEs, and much more at the IPBC

The first full day of the IPBC Global in San Francisco is now done and dusted. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights from the sessions and from the conversations…